FDA Inspection
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA Inspection, Feb 5, 2026
Record Details
This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on February 5, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 34708a56-41e8-4e87-bab0-c702d71a2713
Inspection Facts
- Inspection number
- 1302186
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 600.80(c)(1)(i)Reporting Requirements - 15-day alert
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Grifols Therapeutics LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2023 | Not classified | Atlanta District Office | |
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2017 | Not classified | Atlanta District Office | |
| October 21, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.